Serum Inhibin A Level in Preeclampsia and Normotensive Pregnancy

REFERENCES

• Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999; 341: 461–467
   PubMed Web of Science ®Google Scholar
• Lambert-Messerlian GM, Canick JA. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome. Semin Reprod Med 2004; 22: 235–242
   Google Scholar
• D'Anna R, Baviera G, Corrado F, Leonardi I, Buemi M, Jasonni VM. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?. Acta Obstet Gynecol Scand 2002; 81: 540–543
   PubMed Web of Science ®Google Scholar
• Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 2002; 99: 267–274
   PubMed Web of Science ®Google Scholar
• Florio P, Luisi S, D'Antona D, Severi FM, Rago G, Petraglia F. Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil Steril 2004; 81: 468–470
   PubMedGoogle Scholar
• Al-Azemi M, Ledger WL, Diejomaoh M, Mousa M, Makhseed M, Omu A. Measurement of inhibin A and inhibin pro-alphaC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss. Fertil Steril 2003; 80: 1473–1479
   Google Scholar
• MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533–538
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785–799
   PubMed Web of Science ®Google Scholar
• Reis FM, D'Antona D, Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 2002; 23: 230–257
   PubMed Web of Science ®Google Scholar
• Muttukrishna S. Role of inhibin in normal and high-risk pregnancy. Semin Reprod Med 2004; 22: 227–234
   Google Scholar
• Birdsall M, Ledger W, Groome N, Abdalla H, Muttukrishna S. Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab 1997; 82: 1557–1560
   Google Scholar
• Silver HM, Lambert-Messerlian GM, Reis FM, Diblasio AM, Petraglia F, Canick JA. Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia. J Soc Gynecol Investig 2002; 9: 308–312
   PubMedGoogle Scholar
• Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000; 15: 1640–1645
   PubMed Web of Science ®Google Scholar
• ACOG. Diagnosis and management of preeclampsia and eclampsia. ACOG practical bulletin. Clinical management guidelines for obstetrician-gynecologists Number 33, January 2002. Obstet Gynecol 2002; 99: 159–166
   PubMed Web of Science ®Google Scholar
• Phupong V, Hanprasertpong T, Honsawek S. First trimester serum inhibin A in normal pregnant women. Arch Gynecol Obstet 2007, DOI 10.1007/s00404–007–0491–5
   Google Scholar
• Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf) 1995; 42: 391–397
   Google Scholar
• Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999; 180: 1131–1137
   PubMed Web of Science ®Google Scholar
• Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997; 349: 1285–1288
   PubMed Web of Science ®Google Scholar
• Zeeman GG, Alexander JM, McIntire DD, Byrd W, Leveno KJ. Inhibin-A and superimposed preeclampsia in women with chronic hypertension. Obstet Gynecol 2003; 101: 232–236
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Smarason AK, Muttukrishna S, Groome NP, Redman CW. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy 2003; 22: 45–55
   PubMed Web of Science ®Google Scholar
• Hamar BD, Buhimschi IA, Sfakianaki AK, Pettker CM, Magloire LK, Funai EF, et al. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia. Am J Obstet Gynecol 2006; 195: 1636–1645
   PubMedGoogle Scholar
• Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 365–372
   PubMedGoogle Scholar
• Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12: 301–8
   PubMed Web of Science ®Google Scholar
• Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol 1999; 42: 422–435
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Benattar C, Audibert F, Fernandez H, Duyme M, Taieb J, et al. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003; 189: 1517–1522
   PubMed Web of Science ®Google Scholar
• Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B, Duhamel A, et al. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Fertil Steril 2000; 73: 972–977
   PubMedGoogle Scholar
• Auge AP, Longui CA, Almeida Prado RA, Rocha MN, Hirota A, Busso NE, et al. Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance. Gynecol Endocrinol 2005; 21: 7–11
   PubMed Web of Science ®Google Scholar